ImmunityBio (IBRX) Prepaid Assets (2014 - 2026)
ImmunityBio (IBRX) reported Prepaid Assets of $3.0 million for Q1 2026, down 86.05% year-over-year from $21.7 million in Q1 2025, and up 41.59% on a QoQ basis from $2.1 million in Q4 2025.
ImmunityBio (IBRX) has 13 years of Prepaid Assets data on file, last reported at $3.0 million in Q1 2026.
- Quarterly Prepaid Assets fell 86.05% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (down 86.05% YoY) and the FY2025 annual result came in at $2.1 million, down 91.05% from the prior year.
- Prepaid Assets climbed to $3.0 million in Q1 2026 per IBRX's latest filing, from $2.1 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $32.9 million in Q3 2025 and bottomed at $480000.0 in Q2 2024.
- The 5-year median for Prepaid Assets is $4.6 million (2023), against an average of $14.0 million.
- Peak annual rise in Prepaid Assets reached 5213.33% in 2025, while the deepest fall reached 91.05% in 2025.
- Tracing IBRX's Prepaid Assets over 5 years: stood at $31.5 million in 2022, then decreased by 18.73% to $25.6 million in 2023, then retreated by 6.84% to $23.9 million in 2024, then tumbled by 91.05% to $2.1 million in 2025, then soared by 41.59% to $3.0 million in 2026.
- Per Business Quant, the three latest IBRX Prepaid Assets figures stand at $3.0 million (Q1 2026), $2.1 million (Q4 2025), and $32.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.02 Mn |
| Dec 31, 2025 | 2.14 Mn |
| Sep 30, 2025 | 32.95 Mn |
| Jun 30, 2025 | 25.50 Mn |
| Mar 31, 2025 | 21.68 Mn |
| Dec 31, 2024 | 23.85 Mn |
| Sep 30, 2024 | 1.37 Mn |
| Jun 30, 2024 | 480,000.00 |
| Mar 31, 2024 | 2.58 Mn |
| Dec 31, 2023 | 25.60 Mn |
| Sep 30, 2023 | 4.38 Mn |
| Jun 30, 2023 | 4.55 Mn |
| Mar 31, 2023 | 20.75 Mn |
| Dec 31, 2022 | 31.50 Mn |
| Sep 30, 2022 | 3.24 Mn |
| Jun 30, 2022 | 30.60 Mn |
| Mar 31, 2022 | 3.98 Mn |
| Dec 31, 2021 | 2.96 Mn |
| Sep 30, 2021 | 12.78 Mn |
| Jun 30, 2021 | 7.76 Mn |
| Mar 31, 2021 | 1.23 Mn |
| Dec 31, 2020 | 13.65 Mn |
| Sep 30, 2020 | 657,000.00 |
| Jun 30, 2020 | 414,000.00 |
| Mar 31, 2020 | 78,000.00 |
| Dec 31, 2019 | 372,000.00 |
| Sep 30, 2019 | 5.56 Mn |
| Jun 30, 2019 | 51,000.00 |
| Mar 31, 2019 | 80,000.00 |
| Dec 31, 2018 | 536,000.00 |
| Sep 30, 2018 | 16.43 Mn |
| Jun 30, 2018 | 375,000.00 |
| Mar 31, 2018 | 373,000.00 |
| Dec 31, 2017 | 572,000.00 |
| Sep 30, 2017 | 816,000.00 |
| Jun 30, 2017 | 302,000.00 |
| Mar 31, 2017 | 371,000.00 |
| Dec 31, 2016 | 360,000.00 |
| Sep 30, 2016 | 287,000.00 |
| Jun 30, 2016 | 11,000.00 |
| Mar 31, 2016 | 298,000.00 |
| Dec 31, 2015 | 3.11 Mn |
| Sep 30, 2015 | 1.67 Mn |
| Jun 30, 2015 | 388,000.00 |
| Dec 31, 2014 | 9,000.00 |